Aphria Inc (NYSE:APHA)

10.38
Delayed Data
As of Feb 21
 +0.23 / +2.27%
Today’s Change
3.75
Today|||52-Week Range
16.86
+82.43%
Year-to-Date
4 Reasons Why Marijuana Stocks & ETFs Could Be on a High in 2019
Feb 15 / Zacks.com - Paid Partner Content
Why Marijuana ETFs are on a High in 2019
Feb 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close10.15
Today’s open10.27
Day’s range10.20 - 10.53
Volume7,401,154
Average volume (3 months)7,329,261
Market cap$2.4B
Data as of 4:01pm ET, 02/21/2019

Growth & Valuation

Earnings growth (last year)+342.55%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+87.91%
P/E ratio39.2
Price/Sales50.76
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
USNAUSANA Health Science...+3.92+3.94%
ARGXargenx SE-3.13-2.50%
CRONCronos Group Inc+0.24+1.08%
LJPCLa Jolla Pharmaceuti...+0.09+1.54%
Data as of 4:02pm ET, 02/21/2019

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$27.8M
Annual profit (last year)$22.1M
Net profit margin79.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Victor Neufeld
President
Jakob Ripshtein
Corporate headquarters
Leamington, Ontario

Forecasts